Harada, K., Song, S., Baba, H., & Ajani, J. A. (2017). Is phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway therapeutic target for esophageal adenocarcinoma. Shanghai Chest.
Citación estilo ChicagoHarada, Kazuto, Shumei Song, Hideo Baba, y Jaffer A. Ajani. "Is Phosphatidylinositol 3-kinase/AKT/mammalian Target of Rapamycin Pathway Therapeutic Target for Esophageal Adenocarcinoma." Shanghai Chest 2017.
Cita MLAHarada, Kazuto, Shumei Song, Hideo Baba, y Jaffer A. Ajani. "Is Phosphatidylinositol 3-kinase/AKT/mammalian Target of Rapamycin Pathway Therapeutic Target for Esophageal Adenocarcinoma." Shanghai Chest 2017.
Precaución: Estas citas no son 100% exactas.